2.50
Hdl Handle:
http://hdl.handle.net/10755/149994
Type:
Presentation
Title:
Expressive Writing in Newly Diagnosed Breast Cancer Patients
Abstract:
Expressive Writing in Newly Diagnosed Breast Cancer Patients
Conference Sponsor:Sigma Theta Tau International
Conference Year:2005
Author:Craft, Melissa, RN, MS, AOCN
P.I. Institution Name:Breast Imaging of Oklahoma
Title:Oncology Clinical Nurse Specialist
A diagnosis of breast cancer can lead to physical, cognitive and affective distress (Cimprich, 1999). Positive benefits of expressive writing have been reported in other groups dealing with traumatic events (Pennebaker, 1986). Expressive writing has been studied to a limited degree in breast cancer patients; however several questions remain about the specific writing type that is most beneficial to this group, and the impact expressive writing has on physical and psychological distress. This study is a longitudinal randomized controlled trial evaluating the use of expressive writing in newly diagnosed breast cancer patients (< 2 years since diagnosis). Reflection/reframing (Mezirow, 1978) and caring consciousness (Watson, 2002) provide the theoretical framework to explore the events that occur when a person experiences a life-altering experience and does expressive writing. Positive benefits seen in other populations using expressive writing include improved physical and psychological well-being. Participants will be recruited from multiple sites in central Oklahoma and randomized to three intervention writing groups and one control group. Depression, anxiety and quality of life will be measured at pre-test, one-month and 6 months posttest. Findings from this study will provide information for evidenced-based practice about an intervention women might use following a diagnosis of breast cancer.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleExpressive Writing in Newly Diagnosed Breast Cancer Patientsen_GB
dc.identifier.urihttp://hdl.handle.net/10755/149994-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Expressive Writing in Newly Diagnosed Breast Cancer Patients</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2005</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Craft, Melissa, RN, MS, AOCN</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Breast Imaging of Oklahoma</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Oncology Clinical Nurse Specialist</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">mcraft@breastok.com</td></tr><tr><td colspan="2" class="item-abstract">A diagnosis of breast cancer can lead to physical, cognitive and affective distress (Cimprich, 1999). Positive benefits of expressive writing have been reported in other groups dealing with traumatic events (Pennebaker, 1986). Expressive writing has been studied to a limited degree in breast cancer patients; however several questions remain about the specific writing type that is most beneficial to this group, and the impact expressive writing has on physical and psychological distress. This study is a longitudinal randomized controlled trial evaluating the use of expressive writing in newly diagnosed breast cancer patients (< 2 years since diagnosis). Reflection/reframing (Mezirow, 1978) and caring consciousness (Watson, 2002) provide the theoretical framework to explore the events that occur when a person experiences a life-altering experience and does expressive writing. Positive benefits seen in other populations using expressive writing include improved physical and psychological well-being. Participants will be recruited from multiple sites in central Oklahoma and randomized to three intervention writing groups and one control group. Depression, anxiety and quality of life will be measured at pre-test, one-month and 6 months posttest. Findings from this study will provide information for evidenced-based practice about an intervention women might use following a diagnosis of breast cancer.</td></tr></table>en_GB
dc.date.available2011-10-26T10:14:07Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T10:14:07Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.